Companies / Supernus Pharmaceuticals Inc / Activity
Activity — Supernus Pharmaceuticals Inc
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $4.69M | +91K | 90,821 0.16% of shares | low |
| Q1 2026 as of | Natixis 13F manager | New | Common stock | $4.40M | +85K | 85,200 0.15% of shares | low |
| Q1 2026 as of | Capital Fund Management S.A. 13F manager | New | Common stock | $1.54M | +30K | 29,715 0.05% of shares | low |
| Q2 2024 as of | Danske Bank A/S 13F manager | New | Common stock | $604.1K | +23K | 22,583 0.04% of shares | low |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $348.3K | +7K | 6,738 0.01% of shares | low |
| Q4 2025 as of | Sanctuary Advisors, LLC 13F manager | New | Common stock | $337.7K | +7K | 6,795 0.01% of shares | low |
| Q1 2026 as of | Cornerstone Investment Partners, LLC 13F manager | New | Common stock | $267.1K | +5K | 5,168 <0.01% of shares | low |
| Q1 2026 as of | Magnetar Financial LLC 13F manager | New | Common stock | $252.3K | +5K | 4,881 <0.01% of shares | low |
| Q4 2021 as of | Leonteq Securities AG 13F manager | New | Common stock | $15.2K | +520 | 520 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $776 | +15 | 15 <0.01% of shares | low |
| Q1 2026 as of | Northwestern Mutual Wealth Management Co 13F manager | New | Common stock | $155 | +3 | 3 <0.01% of shares | low |